Dutch Study Finds Exome Sequencing Could Cut Costs for Dx in Children With Intellectual Disability | GenomeWeb

NEW YORK (GenomeWeb) – Applying whole-exome sequencing early in difficult-to-diagnose patients with intellectual disability could lead to substantial cost savings by preventing further diagnostic tests and procedures, regardless of whether the patient receives a diagnosis or not, according to a pilot study by researchers at the Utrecht University Medical Center in the Netherlands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.

Sponsored by
Personal Genome Diagnostics

This webinar will discuss genomic methods to elucidate the molecular mechanisms underlying acquired resistance to immuno-oncology (IO) therapies.


This webinar describes the optimization and validation of two commercially available next-generation sequencing assays that may be used to guide personalized cancer treatment.